Clinical Oncology » Cancer Center ...

Dr. Thomas J. George

Claim this profile

University of Florida Health Science Center - Gainesville

Expert in Cancer
Expert in Uterine Tumors
34 reported clinical trials
105 drugs studied

About Thomas J. George

Education:

  • Earned an MD (Doctor of Medicine).

Experience:

  • Serves as the Director of the GI Oncology Program at the University of Florida, focusing on gastrointestinal malignancies and new cancer therapy development.
  • Acted as the chair of the Medical Advisory Board to the State of Florida Department of Health and completed a 10-year term as the gubernatorial-appointed chair of the Florida Cancer Control and Research.
  • Holds the position of Deputy Director at the UF Health Cancer Center.
  • Board Certified in Hematology, Internal Medicine, and Oncology.

Area of expertise

1Cancer
Global Leader
Thomas J. George has run 16 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
KRAS positive
2Uterine Tumors
Global Leader
Thomas J. George has run 15 trials for Uterine Tumors. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive

Affiliated Hospitals

Image of trial facility.
University Of Florida Health Science Center - Gainesville
Image of trial facility.
University Of Florida

Clinical Trials Thomas J. George is currently running

Image of trial facility.

Chemotherapy + Immunotherapy

for Esophageal and Gastric Cancer

This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Image of trial facility.

Energy Drinks and Gut Bacteria Changes

for undefined

This study will investigate whether short-term daily energy drink consumption results in an increase in hydrogen sulfide-producing bacteria in adults 18-40 years old.
Recruiting1 award Phase 21 criteria

More about Thomas J. George

Clinical Trial Related7 years of experience running clinical trials · Led 34 trials as a Principal Investigator · 16 Active Clinical Trials
Treatments Thomas J. George has experience with
  • Nivolumab
  • Pembrolizumab
  • Olaparib
  • Oxaliplatin
  • Fluorouracil
  • Binimetinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas J. George specialize in?
Thomas J. George focuses on Cancer and Uterine Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thomas J. George currently recruiting for clinical trials?
Yes, Thomas J. George is currently recruiting for 16 clinical trials in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that Thomas J. George has studied deeply?
Yes, Thomas J. George has studied treatments such as Nivolumab, Pembrolizumab, Olaparib.
What is the best way to schedule an appointment with Thomas J. George?
Apply for one of the trials that Thomas J. George is conducting.
What is the office address of Thomas J. George?
The office of Thomas J. George is located at: University of Florida Health Science Center - Gainesville, Gainesville, Florida 32610 United States. This is the address for their practice at the University of Florida Health Science Center - Gainesville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.